Premium
Letter to the Editor: mTOR‐Inhibitor‐Based Immunosuppression Following Liver Transplantation for Hereditary Hemorrhagic Telangiectasia
Author(s) -
Castellote Jose,
Mora Luján José Maria,
RieraMestre Antoni
Publication year - 2020
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.30870
Subject(s) - medicine , calcineurin , telangiectasia , liver transplantation , sirolimus , bevacizumab , immunosuppression , pi3k/akt/mtor pathway , transplantation , tacrolimus , oncology , cancer research , pathology , chemotherapy , signal transduction , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom